NCT01366339View on ClinicalTrials.gov

Tolerance and Pharmacokinetics Study of MNTX Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Normal Healthy Volunteers
Interventions
DRUG

Oral methylnaltrexone

DRUG

Oral placebo

Trial Locations (1)

10591

Progenics Pharmaceuticals, Inc., Tarrytown

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT01366339 - Tolerance and Pharmacokinetics Study of MNTX Tablets | Biotech Hunter | Biotech Hunter